• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经脑保护装置时代经导管主动脉瓣置换术后的脑卒中结局和预测因素。

Outcomes and Predictors of Stroke After Transcatheter Aortic Valve Replacement in the Cerebral Protection Device Era.

机构信息

Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic Cleveland OH USA.

出版信息

J Am Heart Assoc. 2024 Aug 6;13(15):e034298. doi: 10.1161/JAHA.124.034298. Epub 2024 Aug 5.

DOI:10.1161/JAHA.124.034298
PMID:39101495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11964015/
Abstract

BACKGROUND

Studies have shown inconclusive results on the effectiveness of cerebral protection devices (CPDs) with transcatheter aortic valve replacement. We aimed to analyze the national statistics on stroke and other outcomes with CPD use.

METHODS AND RESULTS

The Nationwide Readmissions Database (2017-2020) was queried to obtain data on patients undergoing transcatheter aortic valve replacement. Outcomes were compared between patients with a CPD and patients without a CPD. Of 271 804 patients undergoing transcatheter aortic valve replacement, CPD was used in 7.3% of patients. In a multivariable logistic regression analysis, CPD use was not associated with lower overall stroke rates (1.6% versus 1.9% without CPD; odds ratio, 0.95 [95% CI, 0.84-1.07]; =0.364), but it was significantly associated with lower major stroke rates (1.2% versus 1.5% without CPD; odds ratio, 0.85 [95% CI, 0.74-0.98]; =0.02). Patients with a CPD also had a shorter length of stay, higher routine discharges to home/self-care (74.9% versus 70.6%), and lower mortality rates (0.7% versus 1.3%). The 30-day (9.6% versus 11.7%) and 180-day (24.6% versus 28.2%) readmission rates were significantly lower in the CPD cohort. Among patients who developed stroke, patients with a CPD had more frequent routine discharges. Prior valve surgery was associated with the highest risk of overall and major stroke.

CONCLUSIONS

CPD use during transcatheter aortic valve replacement was not independently associated with a lower risk of overall stroke but was associated with a lower risk of major stroke in a multivariable model. Data from future randomized trials that may offset any potential confounders in our study are required to help identify patients who would benefit from the use of these devices.

摘要

背景

研究表明,经导管主动脉瓣置换术中使用脑保护装置(CPD)的效果尚无定论。我们旨在分析 CPD 使用与中风和其他结局的全国统计数据。

方法和结果

从全国再入院数据库(2017-2020 年)中检索接受经导管主动脉瓣置换术的患者数据。将使用 CPD 的患者与未使用 CPD 的患者的结局进行比较。在 271804 例接受经导管主动脉瓣置换术的患者中,7.3%的患者使用了 CPD。在多变量逻辑回归分析中,CPD 的使用与较低的总体中风发生率无关(CPD 组为 1.6%,无 CPD 组为 1.9%;优势比,0.95[95%CI,0.84-1.07];=0.364),但与较低的主要中风发生率显著相关(CPD 组为 1.2%,无 CPD 组为 1.5%;优势比,0.85[95%CI,0.74-0.98];=0.02)。使用 CPD 的患者的住院时间更短,常规出院回家/自我护理的比例更高(74.9%比 70.6%),死亡率更低(0.7%比 1.3%)。CPD 组的 30 天(9.6%比 11.7%)和 180 天(24.6%比 28.2%)再入院率显著降低。在发生中风的患者中,使用 CPD 的患者常规出院的比例更高。既往瓣膜手术与总体和主要中风的风险最高相关。

结论

在经导管主动脉瓣置换术中使用 CPD 与总体中风风险降低无关,但与多变量模型中的主要中风风险降低相关。需要来自未来随机试验的数据来帮助确定哪些患者将从这些设备的使用中获益,这些数据可能会抵消我们研究中的任何潜在混杂因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac84/11964015/9b10157b4834/JAH3-13-e034298-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac84/11964015/9b10157b4834/JAH3-13-e034298-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac84/11964015/9b10157b4834/JAH3-13-e034298-g001.jpg

相似文献

1
Outcomes and Predictors of Stroke After Transcatheter Aortic Valve Replacement in the Cerebral Protection Device Era.经脑保护装置时代经导管主动脉瓣置换术后的脑卒中结局和预测因素。
J Am Heart Assoc. 2024 Aug 6;13(15):e034298. doi: 10.1161/JAHA.124.034298. Epub 2024 Aug 5.
2
Cerebral embolic protection device utilization and outcomes in transcatheter aortic valve replacement: A nationally representative propensity matched analysis.经导管主动脉瓣置换术中脑栓塞保护装置的应用及结局:一项全国代表性倾向评分匹配分析。
Cardiovasc Revasc Med. 2024 Oct;67:112-114. doi: 10.1016/j.carrev.2024.04.003. Epub 2024 Apr 4.
3
Use and outcomes of cerebral embolic protection for transcatheter aortic valve replacement: A US nationwide study.经导管主动脉瓣置换术中使用脑保护装置的情况及结果:一项美国全国性研究。
Catheter Cardiovasc Interv. 2021 Nov 1;98(5):959-968. doi: 10.1002/ccd.29842. Epub 2021 Jun 19.
4
Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.经导管主动脉瓣置换术中脑保护显著降低死亡率和卒率,优于无保护手术。
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2297-2303. doi: 10.1016/j.jcin.2017.06.037. Epub 2017 Sep 13.
5
Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.经导管主动脉瓣置换术中使用前哨式脑保护系统的临床结局:系统评价和荟萃分析。
Cardiovasc Revasc Med. 2020 Jun;21(6):717-722. doi: 10.1016/j.carrev.2019.04.023. Epub 2019 Apr 25.
6
Safety and efficacy of cerebral protection devices in transcatheter aortic valve replacement: A clinical end-points meta-analysis.经导管主动脉瓣置换术中脑保护装置的安全性和有效性:一项临床终点荟萃分析。
Cardiovasc Revasc Med. 2018 Oct;19(7 Pt A):785-791. doi: 10.1016/j.carrev.2018.02.009. Epub 2018 Feb 16.
7
Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry.经心尖主动脉瓣置换术(TAVR)后使用脑保护装置对致残性卒中的影响:STS/ACC TVT 注册研究的更新结果。
Circ Cardiovasc Interv. 2024 Sep;17(9):e013697. doi: 10.1161/CIRCINTERVENTIONS.123.013697. Epub 2024 Jun 5.
8
Temporal Trends, Outcomes, and Predictors of Next-Day Discharge and Readmission Following Uncomplicated Evolut Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis.经皮主动脉瓣置换术后无并发症患者次日出院和再入院的时间趋势、结局及预测因素:倾向评分匹配分析。
J Am Heart Assoc. 2024 May 7;13(9):e033846. doi: 10.1161/JAHA.123.033846. Epub 2024 Apr 19.
9
Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.经导管主动脉瓣置换术患者应用栓塞保护装置的神经学结局:随机对照试验的系统评价和荟萃分析。
JACC Cardiovasc Interv. 2016 Oct 24;9(20):2124-2133. doi: 10.1016/j.jcin.2016.07.024.
10
Temporal Trends and Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis.经导管主动脉瓣置换术与外科主动脉瓣置换术治疗二叶式主动脉瓣狭窄的时间趋势和结局。
JACC Cardiovasc Interv. 2019 Sep 23;12(18):1811-1822. doi: 10.1016/j.jcin.2019.06.037.

引用本文的文献

1
The Next Chapter in TAVR: Innovations and the Road Ahead.经导管主动脉瓣置换术的新篇章:创新与未来之路。
J Clin Med. 2025 Jun 25;14(13):4504. doi: 10.3390/jcm14134504.
2
Remimazolam in the perioperative setting: an answer in search of an ideal question.围手术期使用瑞米唑仑:寻求理想问题的答案。
Can J Anaesth. 2025 Mar;72(3):378-383. doi: 10.1007/s12630-024-02899-8. Epub 2024 Dec 23.

本文引用的文献

1
Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis.经导管主动脉瓣植入术中脑栓塞保护装置降低卒中发生率的系统评价和贝叶斯荟萃分析。
Heart. 2024 May 10;110(11):757-765. doi: 10.1136/heartjnl-2023-323359.
2
Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement: A Meta-analysis of Randomized Controlled Trials.经导管主动脉瓣置换术中的脑栓塞保护装置:随机对照试验的荟萃分析
J Soc Cardiovasc Angiogr Interv. 2023 Sep-Oct;2(5):None. doi: 10.1016/j.jscai.2023.101031.
3
Cerebral embolic protection during transcatheter heart interventions.
经导管心脏介入术中的脑栓塞保护。
EuroIntervention. 2023 Sep 18;19(7):549-570. doi: 10.4244/EIJ-D-23-00166.
4
An Updated Meta-Analysis on Cerebral Embolic Protection in Patients Undergoing Transcatheter Aortic Valve Intervention Stratified by Baseline Surgical Risk and Device Type.一项关于经导管主动脉瓣介入治疗患者脑栓塞保护的最新荟萃分析,按基线手术风险和器械类型分层。
Struct Heart. 2023 Apr 4;7(4):100178. doi: 10.1016/j.shj.2023.100178. eCollection 2023 Jul.
5
Safety and efficacy of cerebral embolic protection devices for patients undergoing transcatheter aortic valve replacement: An updated meta-analysis.经导管主动脉瓣置换术患者使用脑栓塞保护装置的安全性和有效性:一项更新的荟萃分析。
Health Sci Rep. 2023 Jul 1;6(7):e1391. doi: 10.1002/hsr2.1391. eCollection 2023 Jul.
6
Outcomes of Cerebral Embolic Protection for Bicuspid Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术治疗二叶式主动脉瓣狭窄的脑保护效果。
J Am Heart Assoc. 2023 Jun 20;12(12):e028890. doi: 10.1161/JAHA.122.028890. Epub 2023 Jun 10.
7
Meta-Analysis of Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术中脑栓塞保护的Meta分析
Am J Cardiol. 2023 Apr 1;192:255-257. doi: 10.1016/j.amjcard.2023.01.019. Epub 2023 Feb 27.
8
Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Clinical Trials.经导管主动脉瓣置换术中的脑栓塞保护:随机临床试验的荟萃分析
Am J Cardiol. 2023 Jan 15;187:179-180. doi: 10.1016/j.amjcard.2022.10.032. Epub 2022 Nov 14.
9
Role of Changing Procedural Characteristics Versus Changing Risk Profile in Age-Based Trends of Outcomes in Patients With Transfemoral Transcatheter Aortic Valve Replacement From 2012 to 2018: A Nationwide Analysis.2012 年至 2018 年经股动脉行主动脉瓣置换术患者的年龄相关结局的变化与风险特征在程序特征变化中的作用:一项全国性分析。
J Am Heart Assoc. 2022 Nov 15;11(22):e026812. doi: 10.1161/JAHA.122.026812. Epub 2022 Nov 3.
10
Feasibility of Sentinel Cerebral Embolic Protection Device Deployment During Transfemoral Transcatheter Aortic Valve Replacement.经股动脉导管主动脉瓣置换术中使用脑栓塞保护装置的可行性
Am J Cardiol. 2022 Dec 1;184:157-159. doi: 10.1016/j.amjcard.2022.09.002. Epub 2022 Oct 1.